Similar articles

• Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel.

  Hsu CH, Chen MY, Cheng AL. Hsu CH, et al. Anticancer Res. 2000 Mar-Apr;20(2B):1159-61. Anticancer Res. 2000. PMID: 10810414
• Paclitaxel for AIDS-associated Kaposi's sarcoma.

  Dhillon T, Stebbing J, Bower M. Dhillon T, et al. Expert Rev Anticancer Ther. 2005 Apr;5(2):215-9. doi: 10.1586/14737140.5.2.215. Expert Rev Anticancer Ther. 2005. PMID: 15877519 Review.
• Potential interaction of antiretroviral therapy with paclitaxel in patients with AIDS-related Kaposi's sarcoma.

  Schwartz JD, Howard W, Scadden DT. Schwartz JD, et al. AIDS. 1999 Feb 4;13(2):283-4. doi: 10.1097/00002030-199902040-00019. AIDS. 1999. PMID: 10202837 No abstract available.
• Broad activist support for paclitaxel as second-line treatment for Kaposi's sarcoma.

  [No authors listed] [No authors listed] AIDS Patient Care STDS. 1997 Oct;11(5):375-7. AIDS Patient Care STDS. 1997. PMID: 11361827 No abstract available.
• Treatment update for AIDS-related Kaposi's sarcoma.

  Mihalcea AM, Smith DL, Monini P, Sgadari C, Ensoli B, Gill PS. Mihalcea AM, et al. AIDS. 1999;13 Suppl A:S215-25. AIDS. 1999. PMID: 10885778 Review. No abstract available.